Gisbert Schneider: Catalogue data in Autumn Semester 2020

Name	Prof. Dr. Gisbert Schneider
Field	Computer-Assisted Drug Design
Address	Dep. Biosysteme ETH Zürich, BSS F 57 Klingelbergstrasse 48 4056 Basel SWITZERLAND
Telephone	+41 44 633 73 27
Fax	+41 44 633 13 79
E-mail	gisbert.schneider@bsse.ethz.ch
URL	http://www.modlab.ethz.ch
Department	Chemistry and Applied Biosciences
Relationship	Full Professor

Number	Title	ECTS	Hours	Lecturers
511-0000-00L	Drug Discovery and Development Only for Pharmaceutical Sciences MSc.	2 credits	2G	U. Thibaut, K.‑H. Altmann, J. Hall, J.‑C. Leroux, J. Scheuermann, G. Schneider
Abstract	This course provides an overview over the concepts and processes employed in today's drug discovery and development. It has an introductory character but will also provide more detailed insights employing real life examples. The course combines lectures and interactive elements with active participation of the students.
Learning objective	Students - Understand the drug discovery process and can explain major approaches and relevant technical terms (for details see lecture notes). - Understand and appreciate the content and timing of drug development process steps, development phases and decision criteria. - Understand the concepts underlying drug product development through all the phases from preclinical and clinical development to regulatory submission, approval and market launch. - Can differentiate between small molecule drug development and biological drug development. - Understand the most important differences between legal and regulatory requirements for drug development and approval for the major markets EU and USA.
Content	Drug Discovery (day 1): Introduction to drug discovery: the concepts of drug target selection, ligands/leads, the developability of drug candidates; Overview over the principal approaches to drug discovery: rational drug design, the natural product approach, serendipity, repurposing as well as chemical libraries and high-throughput screening. Drug Development (day 2) Introduction to development processes from the perspective of the pharmaceutical industry. Why and how are decisions for drug development candidates made? What drives portfolio decisions of pharmaceutical companies? Besides stimulating lectures, the course also includes group work on interesting new drugs both from the class of small molecules as well as from biologicals. Drug Development (days 3 and 4): Introduction to the entire suite of drug product development processes in the pharmaceutical industry, covering the following phases: preclinical research and development, clinical development, regulatory processes and market launch. R&D support processes such as project management, quality management, pharmacovigilance and pharmacoeconomics will be covered as well as organizational and governance aspects of the pharmaceutical industry. In addition, important success factors for a later career in the pharmaceutical industry will be discussed and highlighted at the end of the course.
Lecture notes	Will be published on "mystudies"
Literature	G. Nahler (Hrsg.) Dictionary of pharmaceutical medicine, Springer, Wien, 2013 (3rd edition) Further readings will be listed in the lecture notes.
Prerequisites / Notice	This course provides the essential basic knowledge required for the industry-specific modules of the spring semester. Schutzkonzept: https://chab.ethz.ch/studium/bachelor1.html
511-0007-00L	Scientific Writing and Presenting Only for Pharmaceutical Sciences MSc.	2 credits	2G	G. Schneider, J. Dolenc, J. A. Hiss, J.‑C. Leroux, O. Renn
Abstract	This introductory class provides an overview of the basic scientific writing techniques and a guideline to presenting scientific data, together with guided exercises and hands-on training. It is devised to accompany the research projects within the curriculum of the MSc in Pharmaceutical Sciences.
Learning objective	The class enables the participants to prepare their own scientific texts and oral presentations, and critically assess the quality of the presentation of scientific data.
Content	The participants receive an introduction to basic formal aspects of scientific writing and the design of graphical elements. Lectures and topical seminars alternate with practical task for the participants, which will be evaluated in a peer-to-peer setting. Performance feedback is provided by both the teachers and the peers.
535-0001-00L	Introduction to Pharmaceutical Sciences I	2 credits	2V	J. Hall, K.‑H. Altmann, A. Burden, M. Detmar, C. Halin Winter, J.‑C. Leroux, C. Müller, U. Quitterer, J. Scheuermann, R. Schibli, G. Schneider, H. U. Zeilhofer
Abstract	First identification with Pharmaceutical Sciences; motivation for profiling in the Natural Sciences, which are focused on within the first two years as a preparation for the specialized studies; sensitization for the duties and the responsibilities of a person with a federal diploma in Pharmacy; information about job opportunities.
Learning objective	First identification with Pharmaceutical Sciences; motivation for profiling in the Natural Sciences as a preparation for the specialized studies; sensitization for the duties and the responsibilities of a person with a federal diploma in Pharmacy; information about job opportunities.
Content	Introduction to Pharmaceutical Sciences by selected milestones of research and development. Overview on research activities at the Institute of Pharmaceutical Sciences that is focussed on drug delivery and development (from concepts to prototypes). Sensitization for communication skills and information management. Demonstration of job opportunities in community pharmacies, in the hospital, in industry, and in the public sector by experts in the different fields.
Lecture notes	Handouts for individual lectures.
Prerequisites / Notice	Interactive teaching
535-0011-00L	Drug Seminar The course is reserved for students registered in the Master's programme in Pharmacy or in Pharmaceutical Sciences	5 credits	9S	K. Eyer, K.‑H. Altmann, S. M. Ametamey, A. Burden, M. Detmar, C. Halin Winter, J. Hall, S.‑D. Krämer, J.‑C. Leroux, C. Müller, V. I. Otto, U. Quitterer, R. Schibli, G. Schneider, C. Steuer
Abstract	The course provides a platform for the investigation, presentation and discussion of a topic with relevance to the field of pharmaceutical sciences. Students work in small groups on a chosen topic, they write a mini-review and present their work on a one day symposium.
Learning objective	The main objectives of this course are: - students develop their scientific reflection (Critical Thinking) and working skills by working independently on a relevant pharmaceutical topic - students gain in-depth knowledge of the topic investigated - students train their scientific writing and presentation skills - students train their ability to plan a project and work in a team
Content	The Course Drug Seminar takes place during the first 7 weeks of the 1. Master semester. It is a compulsory course of the MSc Pharmacy curriculum and an elective course in the MSc PharmSciences. The course provides a platform for the investigation, presentation and discussion of a topic with relevance to the field of pharmaceutical sciences. During the course, students work in small teams on a topic of their choice and elaborate a written mini-review and an oral presentation. Each team is tutored by a lecturer of the Institute of Pharmaceutical Sciences. The work is mainly based on literature search / review, but may also involve conducting interviews or site visits, if appropriate. The final presentations of all groups will take place in the framework of a dedicated Symposium held in the middle of the semester.
Prerequisites / Notice	Only for students of MSc Pharmacy and MSc Pharmaceutical Sciences.
535-0022-00L	Computer-Assisted Drug Design	1 credit	1V	G. Schneider, F. Grisoni, J. A. Hiss
Abstract	The lecture series provides an introduction to computer applications in medicinal chemistry. A focus is on molecular representations, property predictions, molecular similarity concepts, virtual screening techniques, and de novo drug design. All theoretical concepts and algorithms presented are illustrated by practical applications and case studies
Learning objective	The students will learn how computer simulation generates ideas for drug design and development, understand the theoretical principles of property prediction and computer-generated compound generation, and understand possibilities and limitations of computer-assisted drug design in pharmaceutical chemistry. As a result, they are prepared for professional assessment of computer-assisted drug design studies in medicinal chemistry projects.
Literature	Recommended textbooks: 1) G. Schneider, K.-H. Baringhaus (2008) "Molecular Design - Concepts and Applications", Wiley-VCH: Weinheim, New York. 2) H.-D. Höltje, W. Sippl, D. Rognan, G. Folkers (2008) "Molecular Modeling: Basic Principles and Applications", Wiley-VCH: Weinheim, New York. 3) G. Klebe (2009) "Wirkstoffdesign", Spektrum Akademischer Verlag: Heidelberg.
Prerequisites / Notice	Successful participation in this course is required for a research project ("Forschungspraktikum") in the CADD group.
535-0023-00L	Computer-Assisted Drug Design (Practical Course)	4 credits	6P	G. Schneider, J. A. Hiss
Abstract	The practical course is open for master and graduate students to get an introduction into hands-on computer-assisted drug design. The class includes an introduction to computer-based screening of a virtual compound library, subsequent synthesis of candidate ligands, and biochemically testing for activity on pharmacologically important drug targets.
Learning objective	Participants become familiar with state-of-the-art methodologies in a real-life computer-aided medicinal chemistry project. Participants work as small teams, perform literature research and discuss recent research findings. A seminar talk is to be given presenting the molecular design strategy chosen and the results obtained during the course.
Content	The course offers the possibility for people with and without computational and or laboratory background to get an introduction into computer-assisted drug design, as well as practical training in a modern chemical laboratory. Using various software suites, the participants will computationally create and screen a virtual compound library for potential active small molecules. The process will involve an introduction to screening a virtual compound library, synthesizing candidate inhibitors, and biophysical testing against a pharmacologically important drug target.
Lecture notes	Detailed information will be handed out during the course.
Literature	Textbook: Schneider, G. and Baringhaus, K.-H. (2008) Molecular Design - Concepts and Applications. Wiley-VCH, Weinheim, New York.
Prerequisites / Notice	The class is organized as a two-week block course. The number of participants is limited. To enroll in the course, please consult the lecturer. Kick-off meeting and confirmation of registration (Vorbesprechung und Platzvergabe): During the last lecture of the class "Computer-Assisted Drug Design" (535-0022-00) Ideally, students interested in the course participated and successfully passed the lecture "Computer-Assisted Drug Design" (535-0022-00).
535-0024-00L	Methods in Drug Design Complementary to the practical course "Computer-Assisted Drug Design (Practical Course)" 535-0023-00L . Compulsory for the students of the practical course, open for other interested students.	1 credit	1V	G. Schneider
Abstract	The lecture is organized as a two-week block during the practical course "Computer-Assisted Drug Design" (535-0023-00 P), totalling 10 two-hour lectures. It provides an introduction to advanced drug design techniques and approaches emphasizing computer-assisted molecular design.
Learning objective	Participants will learn about computational algorithms and advanced experimental approaches to drug discovery and design, including selected actual topics and practical applications. The contents of the lecture will allow for a deeper understanding of modern computer-assisted drug design methods and how they are linked to experimental applications. The main focus is on computational medicinal chemistry, so that participants will be able to use relevant computer-based methods in own research projects.
Literature	Schneider, G. and Baringhaus, K.-H. (2008) Molecular Design - Concepts and Applications. Wiley-VCH, Weinheim, New York. Additional selected literature will be provided during the lecture.
Prerequisites / Notice	The lecture is mandatory for all participants of the course "Computer-Assisted Drug Design" (535-0023-00 P).
535-0900-00L	Seminars on Drug Discovery and Development	1 credit	1K	R. Schibli, K.‑H. Altmann, S. M. Ametamey, M. Detmar, C. Halin Winter, J. Hall, J.‑C. Leroux, U. Quitterer, G. Schneider, H. U. Zeilhofer
Abstract	State-of-the-art information on drug discovery and development by experts from academia and industry.
Learning objective	State-of-the-art information on drug discovery and development.
Content	Seminar series of the Institute of Pharmaceutical Sciences. Experts from academia and industry report on relevant topics.
535-2000-00L	Seminar for Group Members	0 credits	2S	G. Schneider
Abstract	Weekly group seminar, in which members of the research team present and discuss the results of their projects and selected reports from the current scientific literature.
Learning objective	Participants learn to present scientific studies and discuss own results in greater context.